Pharmaceutical Imaging Agents

Our imaging agents help healthcare providers make more informed and earlier diagnoses, keep track of patient progress more accurately and develop more tailored patient treatment plans.¹⁻⁴

We provide a comprehensive product range, including both contrast media and radiopharmaceutical imaging agents, so across multiple patient, and procedural needs, we have a diagnostic option to suit.⁵

Enhancing your everyday with:

4/sec

four patient procedures per second supported by our products⁶

4,000+

employees worldwide

$2.3BN

revenue in 2023⁷

Hope enhanced by heritage

We’ve been supporting healthcare providers for over 150 years. Today, we’re a leader in diagnostics, with 110M+ doses of our imaging agents produced globally every year.⁵

Support

Our Pharmaceutical Diagnostics Products

 

Contrast Media

We continually invest in our supply chain to make it one you can count on. In the past decade alone, we’ve invested $400 million in contrast media manufacturing capacity.⁸ And when it comes to iodinated contrast media, we plan to increase dose production by around 30% to deliver 140 million doses by 2024 (that’s equivalent to an extra 30 million doses a year).⁹

 

Molecular Imaging Agents

5 million patients are impacted worldwide by our molecular imaging agents.¹⁰ In the last two decades alone, we’ve supplied over 1.4 million doses of neurology imaging agents worldwide, a patient scanned every 3.5 minutes, supporting differential diagnoses in neurology.¹¹

 

Injectors

With less prep time, streamlined patient turnover and fewer setup steps between patients, the automated syringeless technology of our CT motion power injector helps facilitate efficiencies that keep your radiology suite moving.

Leadership enhanced by logistics

We make punctual delivery a priority, with our network’s global reach supported by over 25 local distribution centers. We also manage supply from extraction to injection, employing end-to-end manufacturing for comprehensive control and agility.¹²

It’s all done so that you can schedule procedures with confidence, knowing that when partnered with GE HealthCare, you can count on us to reliably deliver whenever the need arises.¹²

Spirit enhanced by support

Despite our network’s global reach, we’ve never forgotten that it’s a personal touch that makes all the difference. So, no matter what, our communication lines are open, with dedicated customer service and account management teams always on hand to offer you expert clinical and technical support.13,14 That includes tailored education, from ordering and training to how to seamlessly integrate our products into your workflows.

Our digital platform, MyGEHealthCare experience, also lets you connect with us through one central point of contact, via desktop or mobile. Serving as a digital home, it offers fast access to the       GE HealthCare team and connects you to whatever support you need.¹⁵

Sensitivity enhanced by sustainability

We’re committed to generating sustainable solutions that maximize your impact for patients, while minimizing the impact of care on the planet. That includes reducing the environmental impact of packaging, with our +PLUSPAK bottles having a preferable eco-impact to glass across their entire product lifecycle.¹⁶⁻¹⁸

We also support customers in optimizing the use of contrast media through sustainable initiatives such as our syringeless power injectors and our iodine recycling program.

References
1. Omnipaque US Prescribing Information, April 2023.
2. Visipaque US Prescribing Information, April 2023.
3. Optison US Prescribing Information, September 2021.
4. Clariscan US Prescribing Information, March 2024.
5. GE HealthCare. This is pharmaceutical Diagnostics. October 2023.
6. GE HealthCare Pharmaceutical Diagnostics Patient Impact 1. February 2024.
7. GE HealthCare Pharmaceutical Diagnostics - 2023 Market and Revenue. April 2024
8. GE Healthcare Data on File_Planned Investment 2021.
9. GE HealthCare Data on File_Planned Investment 2022.
10. GEHC website: https://www.gehealthcare.com/services/mygehealthcare-experience. Date accessed: 03.12.24.
11. GEHC DaTscan website: https://www.gehealthcare.com/products/molecular-imaging-agents/datscan. Date accessed: 03.12.24.
12. GE HealthCare. Securing the Future of Iodinated Contrast Media. November 2022.
13. GE HealthCare. So Much More Than A Manufacturer. January 2023.
14. GE HealthCare. RSNA Presentation. November 2023.
15. GEHC Molecular Imaging Agents website: https://www.gehealthcare.com/products/molecular-imaging-agents. Date accessed: 03.27.24.
16. Dhaliwal H, Browne M, Flanagan W, Laurin L, Hamilton M. A life cycle assessment of packaging options for contrast media delivery: comparing polymer bottle vs. glass bottle. Int J Life Cycle Assess. 2014; 19: 1965-73.
17. Belboom S, Renzoni R, Verjans B, Léonard A, Germain A. A life cycle assessment of injectable drug primary packaging: comparing the traditional process in glass vials with the closed vial technology (polymer vials). Int J Life Cycle Assess. 2011;16: 159-67.
18. SINTEF report. HiSense 1997; 6: 14-16.

JB10229US October 2024